Protandim - Reduce Oxidative Stress by 40%

REDUCES OXIDATIVE
STRESS BY AN
AVERAGE OF 40%

Clinical Proof
The induction of human superoxide dismutase and catalase in vivo: A fundamentally new approach to antioxidant therapy, Free Radical Biology and Medicine (2006)
2006 Clinical Protandim Study (pdf)
The results of a peer-reviewed study (Free Radical Biology and Medicine, 2006) showed Protandim eliminates the age-related increase in cell aging factors.
In the clinical trials, blood samples from men and women, young and old, consistently demonstrated that after 30 days, taking one caplet a day, test subjects realized a 40 percent average decrease in TBARS—the progressive aging rate of a 20 year old.
When maintained for 120 days, Protandim significantly increased activity of SOD and CAT antioxidant enzymes by 54 percent, substantially increasing the body’s antioxidant defenses.*

Normal subjects before supplementation with Protandim showed an age-dependent increase in TBARS (blue circles). The levels of TBARS dropped an average of 40% (p<0.0001) after 30 days of Protandim supplementation (green circles), and the age-related increase in TBARS virtually disappeared. This effect (gray circles) was maintained at 120 days with continued Protandim use. Synergistic induction of heme oxygenase-1 by the components of an antioxidant supplement Protandim, Free Radical Biology and Medicine (2008) 2008 Clinical Protandim Study (pdf) Results of a new peer-reviewed study (Free Radical Biology & Medicine, on November 18, 2008) clearly demonstrate that Protandim produces a 300 percent increase in glutathione, which is a key antioxidant and anti-aging factor. In addition, the study shows that Protandim’s synergistic formulation provides more antioxidant power than any food or conventional supplement.

2009 Peer Reviewed Study from Louisiana State, PLoS ONE Journal. 2009 Louisiana State Peer Reviewed Study Peer Reviewed Study from Louisiana State University, "Protandim®, a Fundamentally New Antioxidant Approach in Chemoprevention Using Mouse Two-Stage Skin Carcinogenesis as a Model," Published in PLoS ONE Journal. PROTANDIM HAS BEEN ISSUED TWO PATENTS, IS AWAITING A THIRD AND HAS BEEN FEATURED ON ABC's PRIMETIME.

2006 Clinical Protandim Study (pdf) Protandim has been studied by numerous universities in their own funded trials because scientists who know about the true science of oxidative stress are so excited about the potential. These universities include:

University of Colorado
Denver Health Medical Center Children's Hospital, Denver
Virginia Commonwealth University
Colorado State University
University of Florida
University of Kentucky
University of Michigan
 Louisiana State University
Ohio State University
Vanderbilt University
Glamorgan University, Wales
Sahlgrenska University Hospital, Goteborg, Sweden
University Hospital, Brno, Czech Republic
 Mexican Institute of Social Security, Mexico City

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease